HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improved anti-apoptotic and anti-remodeling potency of bone marrow mesenchymal stem cells by anoxic pre-conditioning in diabetic cardiomyopathy.

AbstractBACKGROUND:
Bone marrow mesenchymal stem cells (MSC) mediate their protection by paracrine mechanism under ischemic conditions and anoxic pre-conditioning (AP) of MSC strongly enhances their survival and regenerative capacity. However, there is no report about the therapeutic potency of MSC transplantation on diabetic cardiomyopathy (DCM), an important cause of heart failure.
METHODS AND RESULTS:
Four months after streptozotocin injection, diabetic rats were randomly given an intramyocardial injection of one of the following: DMEM, MSC, or AP-MSC (no.=10 for each group). Two weeks after transplantation, MSC, especially AP-MSC greatly increased the fractional shortening of diabetic heart (p<0.01, respectively). AP-MSC increased the capillary density of diabetic myocardium and attenuated myocardial fibrosis (p<0.01, respectively) by increasing the activity of matrix metalloproteinase-2 and inhibitiing transforming growth factor beta-1 (p<0.01, respectively). AP-MSC are anti-apoptotic in the rat DCM model, possibly mediated through cardiac upregulation of Bcl-2/Bax ratio (p<0.05) and inhibiting the expression and activation of caspase- 3 (p<0.01).
CONCLUSION:
Intramyocardial transplantation of MSC has a protective effect on diabetic myocardium and anoxic pre-conditioning can enhance this protective effect. AP-MSC transplantation improved cardiac function in the rat DCM model, possibly through an anti-apoptotic effect on diabetic myocarium and attenuation of cardiac remodeling.
AuthorsJ H Li, N Zhang, J A Wang
JournalJournal of endocrinological investigation (J Endocrinol Invest) Vol. 31 Issue 2 Pg. 103-10 (Feb 2008) ISSN: 1720-8386 [Electronic] Italy
PMID18362500 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Transforming Growth Factor beta
  • Vascular Endothelial Growth Factor A
Topics
  • Animals
  • Apoptosis (physiology)
  • Bone Marrow Cells (physiology)
  • Bone Marrow Transplantation
  • Cardiomyopathies (etiology, pathology, physiopathology, therapy)
  • Cell Hypoxia (physiology)
  • Cells, Cultured
  • Coronary Vessels (pathology)
  • Diabetes Mellitus, Experimental (complications, pathology, physiopathology, therapy)
  • Diabetic Angiopathies (physiopathology)
  • Ischemic Preconditioning, Myocardial
  • Male
  • Mesenchymal Stem Cell Transplantation
  • Mesenchymal Stem Cells (physiology)
  • Rats
  • Rats, Sprague-Dawley
  • Transforming Growth Factor beta (metabolism)
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: